Biovest International, the immunotherapy biotech, will be making a presentation at the upcoming Immunotherapy Leaders' Forum 2012, taking place at the Fira Palace in Barcelona, Spain between May 9 and May 11.
There, Carlos F. Santos, Ph.D., Biovest’s Senior Vice President, Product Development & Regulatory Affairs, will present and participate in multiple panel sessions and discussing the Company’s late-stage personalized cancer vaccine for non-Hodgkin’s lymphoma, BiovaxID.
Biovest was recently in the news for their meetings with regulatory officials in Canada about getting their personalized cancer vaccine on the market in that country, as well as an upcoming presentation by the National Cancer Institute to attendees of the American Society of Clinical Oncology's annual meeting in June. There, representatives will discuss trial data supporting BiovaxID against mantle cell lymphoma.
For more information on the Leaders' Forum, click here